What You Should Know:
- The U.S. Department of Health and Human Services (HHS) announced a new final rule today aimed at preventing information blocking in healthcare.
- The final rule establishes disincentives for healthcare providers who engage in practices that interfere with a patient's access to their electronic health information (EHI).
What is Information Blocking?
Information blocking occurs when a healthcare provider knowingly and unreasonably interferes with the
Read More
Most Popular
Evidation Launches MigraineSmart App to Empower Migraine Sufferers with Self-Management Tools & Research Opportunities
What You Should Know:
- Evidation, a company dedicated to improving health measurement in daily life, today announced the launch of MigraineSmart – a program on their app designed to empower migraine sufferers with self-tracking tools and research opportunities.
- Migraine is a chronic and debilitating condition impacting over 40 million Americans, with women disproportionately affected. These migraines significantly impact quality of life, affecting physical and mental health, work
Read More
Alarming Nurse Shortage Threatens Healthcare System, But Solutions Emerge
What You Should Know:
- A new report by Incredible Health, the leading platform for connecting nurses with healthcare employers, paints a concerning picture of the American healthcare system. The report, titled "2024 Healthcare Executive Report," reveals a crisis brewing – a deepening shortage of nurses that threatens patient care.
- The US healthcare system is projected to face a staggering shortage of 1 million nurses by 2030. This alarming gap stems from a growing patient
Read More
Salesforce Launches AI-Powered Life Sciences Cloud for Pharma and MedTech
What You Should Know:
- Salesforce announced the general availability of Life Sciences Cloud, a platform for pharmaceutical (pharma) and medical technology (medtech) organizations to help personalize patient and healthcare professional (HCP) engagement and streamline clinical operations with data, automation, and trusted AI.
- By harnessing the power of AI and automation, it empowers pharma and medtech companies to streamline operations, improve patient care, and ultimately
Read More
Telehealth Company Done CEO Arrested in $100M Adderall Scheme
What You Should Know:
- Two executives from a California telehealth company Done Inc. were arrested on Thursday for allegedly operating a $100M scheme to distribute Adderall and Ritalin to illegitimate patients.
- David Brody, Done's clinical president, and Ruthia He, the founder and CEO, are accused of conspiring to provide easy access to stimulant drugs through online consultations in exchange for monthly subscription fees.
- Federal investigators allege Done prescribed over 40
Read More
KARL STORZ to Acquire Asensus Surgical for $0.35 per Share
What You Should Know:
- Asensus Surgical, Inc. (NYSE American: ASXC), a leading developer of digital surgical technologies, announced today it has entered into a definitive merger agreement with KARL STORZ Endoscopy-America, Inc., a subsidiary of the global medical technology company KARL STORZ SE & Co. KG.
- Asensus Surgical is a pioneer in digital surgery, developing the first intra-operative Augmented Intelligence technology approved for global use. Their LUNA system,
Read More
Nearly 70% of High-Risk Patients Unaware of Chronic Kidney Disease Risk, Study Finds
What You Should Know:
- A new study by Phreesia and the National Kidney Foundation (NKF) reveals a troubling gap in awareness of chronic kidney disease (CKD) among high-risk patients. Published in The American Journal of Accountable Care, the research highlights the importance of patient-provider communication and patient activation in early detection and prevention of CKD, a leading cause of death in the United States.
- The research emphasizes the value of patient education and
Read More
Blood Test for Alzheimer’s on the Horizon: ALZpath Licenses pTau217 Antibody to Roche
What You Should Know:
- ALZpath, a leader in Alzheimer's disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer's disease using Roche's widely used Elecsys® platform.
- The Roche pTau217 test has already received Breakthrough Device designation from the FDA and will be commercialized as part of a collaboration between Roche and Eli Lilly.
pTau217: A Game Changer in
Read More
Waste Management Acquires Stericycle in $7.2B Deal
What You Should Know:
- Waste Management, Inc. (NYSE: WM) and Stericycle (NASDAQ: SRCL) announced today a definitive agreement for WM to acquire Stericycle for $62.00 per share in cash.
- This translates to a total enterprise value of approximately $7.2B, including Stericycle's net debt of $1.4B. The offer represents a 24% premium over Stericycle's 60-day volume-weighted average stock price before a potential sale was reported publicly.
Stericycle: A Leading Player in
Read More
Weave Bio Launches for AI-Powered Drug Development, Secures $10M
What You Should Know:
- Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.
- AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications.
Automating the IND Process: A Game-Changer for Drug
Read More
